Ident. | Authors (with country if any) | Title |
---|
000131 |
Katelijne Van Emmerik-Van Oortmerssen [Pays-Bas] ; Geurt Van De Glind [Pays-Bas] ; Maarten W. J. Koeter [Pays-Bas] ; Steve Allsop [Australie] ; Marc Auriacombe [France] ; Csaba Barta [Hongrie] ; Eli Torild H. Bu [Norvège] ; Yuliya Burren [Suisse] ; Pieter-Jan Carpentier [Pays-Bas] ; Susan Carruthers [Australie] ; Miguel Casas [Espagne] ; Zsolt Demetrovics [Hongrie] ; Geert Dom [Belgique] ; Stephen V. Faraone [États-Unis] ; Melina Fatseas [France] ; Johan Franck [Suède] ; Brian Johnson [États-Unis] ; Máté Kapitany-Föveny [Hongrie] ; Sharlene Kaye [Australie] ; Maija Konstenius [Suède] ; Frances R. Levin [États-Unis] ; Franz Moggi [Suisse] ; Merete M Ller [Norvège] ; J. Antoni Ramos-Quiroga [Espagne] ; Arild Schillinger [Norvège] ; Arvid Skutle [Norvège] ; Sofie Verspreet [Belgique] ; Wim Van Den Brink [Pays-Bas] ; Robert A. Schoevers [Pays-Bas] | Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study |
000143 |
Helen Christensen [Australie] ; Philip James Batterham [Australie] ; Andrew J. Mackinnon [Australie] ; Tara Donker [Australie, Pays-Bas] ; Andrea Soubelet [France] | Predictors of the risk factors for suicide identified by the interpersonal-psychological theory of suicidal behaviour |
000360 |
Alexander Schacht [Allemagne] ; Philip Gorwood [France] ; Philip Boyce [Australie] ; Ayal Schaffer [Canada] ; Hernan Picard [Royaume-Uni] | Depression symptom clusters and their predictive value for treatment outcomes: Results from an individual patient data meta-analysis of duloxetine trials |
000795 |
Albert F. G. Leentjens [Pays-Bas] ; Anja J. H. Moonen [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Sebastian Köhler [Pays-Bas] | Modeling depression in Parkinson disease: Disease-specific and nonspecific risk factors |
000876 |
Michael Maes [Thaïlande] ; Marta Kubera [Pologne] ; Ivana Mihaylova [Bulgarie] ; Michel Geffard [France] ; Piotr Galecki [Pologne] ; Jean-Clude Leunis [Belgique] ; Michael Berk [Australie] | Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression |
000879 |
Michael Maes [Thaïlande, Australie] ; Karl Ringel [Allemagne] ; Marta Kubera [Pologne] ; George Anderson [Royaume-Uni] ; Gerwyn Morris [Royaume-Uni] ; Piotr Galecki [Pologne] ; Michel Geffard [France] | In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation |
000880 |
M. Maes [Thaïlande] ; M. Kubera [Pologne] ; J.-C. Leunis [Belgique] ; M. Berk [Australie] ; M. Geffard [France] ; E. Bosmans [Belgique] | In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes |
000A97 |
Caroline A. Sabin [Royaume-Uni] ; Lene Ryom [Danemark] ; Stephane De Wit [Belgique] ; Amanda Mocroft [Royaume-Uni] ; Andrew N. Phillips [Royaume-Uni] ; Signe W. Worm [Danemark] ; Rainer Weber [Suisse] ; Antonella D'Arminio Monforte [Italie] ; Peter Reiss [Pays-Bas] ; David Kamara [Royaume-Uni] ; Wafaa El-Sadr [États-Unis] ; Christian Pradier [France] ; Francois Dabis [France] ; Matthew Law [Australie] ; Jens Lundgren [Danemark] | Associations between immune depression and cardiovascular events in HIV infection |
000B32 |
Judit Balazs [Hongrie] ; M Nika Miklosi [Hongrie] ; Agnes Kereszteny [Hongrie] ; Christina W. Hoven [États-Unis] ; Vladimir Carli [Suède] ; Camilla Wasserman [États-Unis, Italie] ; Alan Apter [Israël] ; Julio Bobes [Espagne] ; Romuald Brunner [Allemagne] ; Doina Cosman [Roumanie] ; Pádraig Cotter [Irlande (pays)] ; Christian Haring [Autriche] ; Miriam Iosue [Italie] ; Michael Kaess [Allemagne, Australie] ; Jean-Pierre Kahn [France] ; Helen Keeley [Irlande (pays)] ; Dragan Marusic [Slovénie] ; Vita Postuvan [Slovénie] ; Franz Resch [Allemagne] ; Pilar A. Saiz [Espagne] ; Merike Sisask [Estonie] ; Avigal Snir [Israël] ; Alexandra Tubiana [France] ; Airi Varnik [Estonie] ; Marco Sarchiapone [Italie] ; Danuta Wasserman [Suède] | Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk |
000C27 |
Thibault Renoir [Australie] ; Terence Yc Pang [Australie] ; Michelle S. Zajac [Australie] ; Grace Chan [Australie] ; XIN DU [Australie] ; Leah Leang [Australie] ; Caroline Chevarin [France] ; Laurence Lanfumey [France] ; Anthony J. Hannan [Australie] | Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise |
000E52 |
Joanne Ryan [France, Australie] ; Marie-Laure Ancelin [France] | Polymorphisms of Estrogen Receptors and Risk of Depression: Therapeutic Implications |
001192 |
Thibault Renoir [France, Australie] ; Terence Y. Pang [Australie] ; Laurence Lanfumey [France] | Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models |
001215 |
Karen Ritchie [France, Royaume-Uni] ; Isabelle Jaussent [France] ; Florence Portet [France] ; Philippe Courtet [France] ; Alain Malafosse [France, Suisse] ; Jerome Maller [Australie] ; Chantal Meslin [Australie] ; Alain Bonafe [France] ; Emmanuelle Le Bars [France] ; Nicolas Menjot De Champfleur [France] ; Sylvaine Artero [France] ; Marie-Laure Ancelin [France] | Depression in elderly persons subject to childhood maltreatment is not modulated by corpus callosum and hippocampal loss |
001376 |
Trevor R. Norman [Australie] ; Ingrid Cranston [Australie] ; Jeremy A. Irons [Australie] ; Cecilia Gabriel [France] ; Anne Dekeyne [France] ; Mark J. Millan [France] ; Elisabeth Mocaer [France] | Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: A comparison to melatonin and to the 5-HT2c antagonist, S32006 |
001612 |
Christophe Maïano [France] ; Alexandre J. S. Morin [Canada, Australie] ; Jerome Begarie [France] | The Center for Epidemiologic Studies Depression Scale: Factor validity and reliability in a French sample of adolescents with Intellectual Disability |
001638 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] | Symptomatology and Markers of Anxiety Disorders in Parkinson's Disease: A Cross-Sectional Study |
001745 |
A. J. S. Morin [Canada, Australie] ; G. Moullec [France, Canada] ; C. Maiano [France] ; L. Layet [France] ; J.-L. Just [France] ; G. Ninot [France] | Psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) in French clinical and nonclinical adults |
001D44 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Pablo Martinez-Martin [Espagne] | Anxiety Rating Scales in Parkinson's Disease: A Validation Study of the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory, and the Hospital Anxiety and Depression Scale |
001D67 |
Michel Lejoyeux [France] ; Philippe Lehert [Belgique, Australie] | Alcohol-Use Disorders and Depression: Results from Individual Patient Data Meta-Analysis of the Acamprosate-Controlled Studies |
001F54 |
K. De Medeiros [États-Unis] ; P. Robert [France] ; S. Gauthier [Canada] ; F. Stella [Brésil] ; A. Politis [Grèce] ; J. Leoutsakos [États-Unis] ; F. Taragano [Argentine] ; J. Kremer [Argentine] ; A. Brugnolo [Italie] ; A. P. Porsteinsson [États-Unis] ; Y. E. Geda [États-Unis] ; H. Brodaty [Australie] ; G. Gazdag [Hongrie] ; J. Cummings [États-Unis] ; C. Lyketsos [États-Unis] | The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia |
002112 |
C. A. Olsson [Australie] ; D. L. Foley [Australie] ; M. Parkinson-Bates [Australie] ; G. Byrnes [France] ; M. Mckenzie [Australie] ; G. C. Patton [Australie] ; R. Morley [Australie] ; R. J. L. Anney [Irlande (pays)] ; J. M. Craig [Australie] ; R. Saffery [Australie] | Prospects for epigenetic research within cohort studies of psychological disorder: A pilot investigation of a peripheral cell marker of epigenetic risk for depression |
002480 |
Ron De Graaf [Pays-Bas] ; Mirjana Radovanovic [États-Unis, Slovénie] ; Margriet Van Laar [Pays-Bas] ; Brian Fairman [États-Unis] ; Louisa Degenhardt [Australie] ; Sergio Aguilar-Gaxiola [États-Unis] ; Ronny Bruffaerts [Belgique] ; Giovanni De Girolamo [Italie] ; John Fayyad [Liban] ; Oye Gureje [Nigeria] ; Josep Maria Haro [Espagne] ; YUEQIN HUANG [République populaire de Chine] ; Stanislav Kostychenko [Ukraine] ; Jean-Pierre Lepine [France] ; Herbert Matschinger [Allemagne] ; Maria Elena Medina Mora [Mexique] ; Yehuda Neumark [Israël] ; Johan Ormel [Pays-Bas] ; Jose Posada-Vilia [Colombie] ; Dan J. Stein [Afrique du Sud] ; Hisateru Tachimori [Japon] ; J. Elisabeth Wells ; James C. Anthony [États-Unis] | Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence From the Population-based World Health Organization World Mental Health Survey Initiative |
002510 |
Rachel F. Rodgers [France] ; Susan J. Paxton [Australie] ; Henri Chabrol [France] | Depression as a Moderator of Sociocultural Influences on Eating Disorder Symptoms in Adolescent Females and Males |
002A78 |
Mika Kivimaki [Royaume-Uni, Finlande] ; Adam G. Tabak [Royaume-Uni, Hongrie] ; G. David Batty [Royaume-Uni, Australie] ; Archana Singh-Manoux [Royaume-Uni, France] ; Markus Jokela [Royaume-Uni] ; Tasnime N. Akbaraly [Royaume-Uni, France] ; Daniel R. Witte [Danemark] ; Eric J. Brunner [Royaume-Uni] ; Michael G. Marmot [Royaume-Uni] ; Debbie A. Lawlor [Royaume-Uni] | Hyperglycemia, Type 2 Diabetes, and Depressive Symptoms: The British Whitehall II study |
002D78 |
Penelope A. Pollitt [Australie] ; Daniel W. O'Connor [Australie] | What was good about admission to an aged psychiatry ward? The subjective experiences of patients with depression |
002F75 |
G. B. Parker [Royaume-Uni, Australie] ; J. Crawford [Royaume-Uni, Australie] ; D. Hadzi-Pavlovic [Royaume-Uni, Australie] ; Jean Cottraux [France] | Quantified superiority of cognitive behaviour therapy to antidepressant drugs : a challenge to an earlier meta-analysis. Commentary |
003403 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Cristina Sampaio [Portugal] ; Wemer Poewe [Autriche] ; Oliver Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Apathy and Anhedonia Rating Scales in Parkinson's Disease : Critique and Recommendations |
003404 |
Albert F. G. Leentjens [Pays-Bas] ; Kathy Dujardin [France] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Irene H. Richard [États-Unis] ; Sergio E. Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Christina Sampaio [Portugal] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Anxiety Rating Scales in Parkinson's Disease : Critique and Recommendations |
003425 |
K. M. Scott [Nouvelle-Zélande] ; M. Von Korff [États-Unis] ; J. Alonso [Espagne] ; M. Angermeyer [Autriche] ; E. J. Bromet [États-Unis] ; R. Bruffaerts [Belgique] ; G. De Girolamo [Italie] ; R. De Graaf [Pays-Bas] ; A. Fernandez [Espagne] ; O. Gureje [Nigeria] ; Y. He [République populaire de Chine] ; R. C. Kessler [États-Unis] ; V. Kovess [France] ; D. Levinson [Israël] ; M. E. Medina-Mora [Mexique] ; Z. Mneimneh [Liban] ; M. A. Oakley Browne [Australie] ; J. Posada-Villa [Colombie] ; H. Tachimori [Japon] ; D. Williams [États-Unis] | Age patterns in the prevalence of DSM-IV depressive/anxiety disorders with and without physical co-morbidity |
003813 |
J. Espallergues [France] ; P. Lapalud [France] ; A. Christopoulos [Australie] ; V. A. Aviani [Australie] ; P. M. Sexton [Australie] ; A. Vamvakides [Grèce] ; T. Maurice [France] | Involvement of the sigma1 (σ1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41 |
003814 |
J. Espallergues [France] ; P. Lapalud [France] ; A. Christopoulos [Australie] ; V. A. Aviani [Australie] ; P. M. Sexton [Australie] ; A. Vamvakides [Grèce] ; T. Maurice [France] | Involvement of the sigma1 (σ1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41 |
003857 |
Marie Preau [France] ; Fabienne Marcellin [France] ; Marie Patrizia Carrieri [France] ; France Lert [France] ; Yolande Obadia [France] ; Bruno Spire [France] | Health-related quality of life in French people living with HIV in 2003 : results from the national ANRS-EN12-VESPA study |
003957 |
M. Berk [Australie] ; S. Dodd [Australie] ; M. Kauer-Sant'Anna [Canada] ; G. S. Malhi [Australie] ; M. Bourin [France] ; F. Kapczinski [Brésil] ; T. Norman [Australie] | Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder |
003959 |
Jacques Joubert [Australie] ; Toby B. Cumming [Australie] ; Allan J. Mclean [Australie] | Diversity of risk factors for stroke : The putative roles and mechanisms of depression and air pollution |
003970 |
Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Depression rating scales in Parkinson's disease : Critique and recommendations |
004647 |
Andrew Holmes [États-Unis] ; Anne Marie Le Guisquet [France] ; Elise Vogel [France] ; Rachel A. Millstein [États-Unis] ; Samuel Leman [France] ; Catherine Belzung [France] | Early life genetic, epigenetic and environmental factors shaping emotionality in rodents |
004C90 |
S. A. Montgomery [Royaume-Uni] ; S. H. Kennedy [Canada] ; G. D. Burrows [Australie] ; M. Lejoyeux [France] ; I. Hindmarch [Royaume-Uni] | Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study |
005589 |
Jeannette Milgrom [Australie] ; Nicole Guedeney ; Nicole Guedeney | Dépistage et traitement de la dépression postnatale (DPN). Une approche cognitiviste et comportementale |
005E68 |
M. Katsikitis [Australie] ; S. Pridmore [Australie] ; M. Marzullo [Australie] | The facial expression measurement system in the assessment of the efficacy of transcranial magnetic stimulation in the treatment of depression |
005F23 |
C. Katona [Royaume-Uni] ; E. Bercoff [France] ; E. Chiu [Australie] ; P. Tack [Belgique] ; M. Versiani [Brésil] ; H. Woelk [Allemagne] | Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial |
006506 |
J. W. Lance [Australie] ; I. Hickie [Brésil] ; D. Wakefield [Australie] ; J. G. Colebatch [Australie] ; F. Cardoso [Brésil] ; M. Vidailhet [France] | An akinetic-rigid syndrome, depression, and stereotypies in a young man |